Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Lidocaine-Tetracaine Cream for Peripheral Neuropathic Pain in Elderly Patients
NCT07396129Phase 2Not yet recruiting
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lidocaine 10% oropharyngeal spray, tetracaine in Peripheral neuropathic pain, sponsored by Pontificia Universidad Católica de Chile. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
lidocaine 10% oropharyngeal spraytetracaine
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT07396129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07396129.